Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for InterCure Ltd. (INCR : NSDQ)

• Company Description    InterCure is a cannabis company. It is a licensed cannabis producer which offer good manufacturing practices certified and pharmaceutical-grade medical cannabis products. InterCure is based in NEW YORK. Number of Employees: 320

• Price / Volume Information    Yesterday's Closing Price: $0.91 Daily Weekly Monthly 20 Day Moving Average: 148,160 shares Shares Outstanding: (millions) Market Capitalization: $ (millions) Beta: 1.21 52 Week High: $1.79 52 Week Low: $0.68 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -31.58% -31.46% 12 Week -45.83% -46.71% Year To Date 0.00% 0.00%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 85 MEDINAT HA-YEHUDIM STREET - HERZLIYA,L3 4676670 ISR ph: 972-77-460-5012 fax: - None http://www.intercure.co

• General Corporate Information    Officers Alexander Rabinovich - Chief Executive Officer and Chairman Amos Cohen - Chief Financial Officer David Salton - Director Lennie Michelson Grinbaum - Director Gideon Hirschfeld - Director Peer Information InterCure Ltd. (BJCT) InterCure Ltd. (CADMQ) InterCure Ltd. (APNO) InterCure Ltd. (UPDC) InterCure Ltd. (IMTIQ) InterCure Ltd. (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: M549GJ111 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: - Next Expected EPS Date: 05/20/26 Share - Related Items Shares Outstanding: Most Recent Split Date: (:1) Beta: 1.21 Market Capitalization: $ (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 05/20/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.34 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 12/31/25 - - 09/30/25 - - 06/30/25 - - ROA 12/31/25 - - 09/30/25 - - 06/30/25 - - Current Ratio 12/31/25 - - 09/30/25 - - 06/30/25 - 1.85 Quick Ratio 12/31/25 - - 09/30/25 - - 06/30/25 - 1.09 Operating Margin 12/31/25 - - 09/30/25 - - 06/30/25 - - Net Margin 12/31/25 - - 09/30/25 - - 06/30/25 - - Pre-Tax Margin 12/31/25 - - 09/30/25 - - 06/30/25 - - Book Value 12/31/25 - - 09/30/25 - - 06/30/25 - 2.65 Inventory Turnover 12/31/25 - - 09/30/25 - - 06/30/25 - - Debt-to-Equity 12/31/25 - - 09/30/25 - - 06/30/25 - 0.27 Debt-to-Capital 12/31/25 - - 09/30/25 - - 06/30/25 - 21.24

Powered by Zacks Investment Research ©